- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.05.2024 | 109 | Xetra Newsboard | Das Instrument DEV US23304Y1001 DBS GROUP ADR/4 SD 1 EQUITY wird ex Kapitalmassnahme gehandelt am 06.05.2024 The instrument DEV US23304Y1001 DBS GROUP ADR/4 SD 1 EQUITY is traded ex capital adjustment... ► Artikel lesen | |
| 29.04. | Biophytis is Deploying its Partnership Strategy in Obesity | 355 | ACCESSWIRE | PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 29, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the... ► Artikel lesen | |
| 25.04. | Biophytis SA - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 25.04. | Pre-market Movers: Barfresh Food, Processa Pharmaceuticals, reAlpha Tech, Biophytis, Meta Platforms | 236 | AFX News | ARMONK (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.25 A.M. ET).In the Green Barfresh Food Group, Inc. (BRFH) is up over 96% at... ► Artikel lesen | |
| 24.04. | Biophytis announces transfer of ADSs to OTC Market following Nasdaq delisting | 5 | Seeking Alpha | ||
| 24.04. | Biophytis Announces Transfer of ADSs to OTC Market | 337 | ACCESSWIRE | ADSs delisted from Nasdaq, which will result in meaningful savingsADSs transferred to OTC Pink market; Company will apply to trade on OTCQB marketBiophytis remains listed on Euronext Growth Paris as... ► Artikel lesen | |
| 23.04. | XFRA 6XB2: AUSSETZUNG/SUSPENSION | 68 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBIOPHYTIS ADR/4000... ► Artikel lesen | |
| 23.04. | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 23.04.2024 | 258 | Xetra Newsboard | The following instruments on XETRA do have their first trading 23.04.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.04.2024
Aktien
1 CA5854671032 Melcor Developments... ► Artikel lesen | |
| 22.04. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.04.2024 | 407 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 22.04.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.04.2024ISIN NameAU0000220865 GCX... ► Artikel lesen | |
| 22.04. | XFRA ISIN CHANGE | 320 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA53681M2058 Lithium Lion Metals Inc. 22.04.2024 CA69867J1057 Lithium Lion Metals Inc. 23.04.2024 Tausch 1:1AU0000220865 GCX... ► Artikel lesen | |
| 22.04. | XFRA CAPITAL ADJUSTMENT INFORMATION - 22.04.2024 | 109 | Xetra Newsboard | Das Instrument 0PD GB00B1JQBT10 PINEWOOD TECH.GR. LS-,05 EQUITY wird cum Kapitalmassnahme gehandelt am 22.04.2024 und ex Kapitalmassnahme am 23.04.2024 The instrument 0PD GB00B1JQBT10 PINEWOOD TECH.GR.... ► Artikel lesen | |
| 19.04. | Biophytis Announces Ratio Change Under its American Depositary Receipt Program | 309 | ACCESSWIRE | PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / April 19, 2024 / Biophytis SA (Nasdaq CM:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized... ► Artikel lesen | |
| 18.04. | Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity | 289 | ACCESSWIRE | IND to be filed with the FDA in the coming weeksPARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 18, 2024 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company")... ► Artikel lesen | |
| 15.04. | Biophytis SA - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 09.04. | Biophytis reports FY results | 3 | Seeking Alpha | ||
| 09.04. | Why Is Penny Stock Biophytis Trading Higher On Tuesday? | 4 | Benzinga.com | ||
| 09.04. | Why Is Biophytis (BPTS) Stock Up 43% Today? | 2 | InvestorPlace | ||
| 09.04. | Biophytis (BPTS) to Begin Phase II Obesity Study, Stock Up | 1 | Zacks | ||
| 09.04. | Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket | 3 | Benzinga.com | ||
| 09.04. | Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities | 446 | ACCESSWIRE | PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 8, 2024 / Biophytis SA (NASDAQ:BPTS), (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
59 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VALNEVA | 3,424 | -2,17 % | Absturz bei Valneva! | Nichts zu feiern gibt es heute für Valneva-Aktionäre. Das Kurstableau weist nämlich ein Minus von rund vier Prozent aus. Mittlerweile kosten die Papiere nur noch 7,24 USD. Ist das nur ein kurzzeitiger... ► Artikel lesen | |
| BIOFRONTERA | 0,358 | +6,55 % | PTA-News: Biofrontera AG: Biofrontera berichtet über die Ergebnisse des Geschäftsjahres 2023 | DJ PTA-News: Biofrontera AG: BIOFRONTERA BERICHTET ÜBER DIE ERGEBNISSE DES GESCHÄFTSJAHRES 2023
Unternehmensmitteilung für den Kapitalmarkt
Leverkusen (pta/30.04.2024/10:15) - Die Biofrontera... ► Artikel lesen | |
| AAP IMPLANTATE | 1,390 | -1,42 % | aap Implantate: Lateinamerika-Geschäft bringt Umsatzplus | aap Implantate meldet Eckdaten für das erste Quartal 2024. Unternehmensangaben vom Montag zufolge konnte der Umsatz in dem Zeitraum von 2,96 Millionen Euro auf 3,12 Millionen Euro erhöht werden. Während... ► Artikel lesen | |
| MAINZ BIOMED | 0,701 | +0,57 % | BRISANTE Meldung setzt Mainz Biomed Aktionäre unter Zugzwang. Bitte reagieren Sie jetzt sofort! | ||
| SANGAMO THERAPEUTICS | 0,486 | -5,39 % | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering | Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that it has entered into a securities purchase agreement with institutional investors, providing for the purchase... ► Artikel lesen | |
| SCORPIUS | 0,175 | +1,16 % | Scorpius Holdings, Inc.: Scorpius Holdings Provides 2023 Year-End Business Update; Reports 570% Sequential Increase in Revenue for the Fourth Quarter of 2023 | DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) ('Scorpius" or "the Company"), an integrated contract development and manufacturing organization providing... ► Artikel lesen | |
| INTELLIA THERAPEUTICS | 22,200 | +1,32 % | Intellia Therapeutics, Inc.: Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates | ||
| VIKING THERAPEUTICS | 72,52 | +1,46 % | Viking Therapeutics mit EILMELDUNG: Könnte der Kurs JETZT komplett drehen - Sofortiges HANDELN erforderlich!!! | ||
| REDHILL BIOPHARMA | 0,430 | +2,87 % | RedHill Biopharma Ltd.: RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 | The new Chinese patent for opaganib as a therapy for inhibition of single-stranded RNA virus replication (notably Ebola Disease Virus) is valid through 2035 and adds to opaganib's strong global intellectual... ► Artikel lesen | |
| AMYRIS | 0,039 | 0,00 % | AMYRIS, INC. - 8-K, Current Report | ||
| BLUEBIRD BIO | 0,961 | +15,11 % | Bluebird reports first commercial cell collection for Lyfgenia | ||
| SAREPTA THERAPEUTICS | 124,00 | -0,16 % | Sarepta Therapeutics Q1 Earnings Summary | WASHINGTON (dpa-AFX) - Below are the earnings highlights for Sarepta Therapeutics (SRPT):Earnings: $36.12 million in Q1 vs. -$516.76 million in the same period last year.
EPS: $0.37 in Q1... ► Artikel lesen | |
| IBIO | 2,000 | +1,01 % | Pre-market Movers: iBio, Direct Digital Holdings, Nuvation Bio, PaySign, LuxUrban Hotels | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.30 A.M. ET).In the Green iBio, Inc. (IBIO) is up over 86% at $2.14.
Nuvation... ► Artikel lesen | |
| BELLEROPHON THERAPEUTICS | 0,001 | -100,00 % | Delisting of Securities of SmileDirectClub, Inc.; Bellerophon Therapeutics, Inc.; Elys Game Technology; Athersys, Inc.; Borqs Technologies; ContraFect Corporation; CohBar, Inc.; AgileThought, Inc.; Fat Projects Acquisition; Evelo Biosciences ... | NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of SmileDirectClub, Inc. SmileDirectClub, Inc.'s securities were suspended on... ► Artikel lesen | |
| GERON | 3,470 | -4,85 % | Geron Corporation Q1 Loss increases, but beats estimates | WASHINGTON (dpa-AFX) - Geron Corporation (GERN) reported Loss for its first quarter that increased from the same period last year but beat the Street estimates.The company's earnings came in... ► Artikel lesen |
BIOPHYTIS SA ADR gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,224 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
